Progestins and vascular function

Drugs of Today

Volumn 32, Issue SUPPL. H, 1996, Pages 25-31

  Kuhl, Herbert ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE ACETATE; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ARTERY BLOOD FLOW; ARTERY WALL; BLOOD VESSEL WALL; CONFERENCE PAPER; ENDOTHELIUM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; SMOOTH MUSCLE FIBER; TRANSDERMAL DRUG ADMINISTRATION; VASOCONSTRICTION; VASODILATATION;

EID: 0030450681     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Kay, C.R. Progestogens and arterial disease - Evidence from the Royal College of General Practitioners study. Amer J Obstet Gynecol 1982, 142: 762-5.
2. World Health Organisation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestogens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995, 346: 1582-8.
3. Jick, H., Jick, S.S., Gurewich, V., Myeres, M.W., Vasilakis, C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestogen components. Lancet 1995,346: 1589-93.
4. Bloemenkamp, K.W.M., Rosendaal, F.R., Helmerhorst, F.M., Büller, H.R., Vandenbrouke, J.P. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestogen. Lancet 1995, 346: 1593-6.
5. Horwitz, K.B., Horwitz, L.D. Canine vascular tissues are targets for androgens, estrogens and progestins, and glucocorticoids. J Clin Invest 1982, 69: 750-8.
6. Lin, A.L., Shain, S.A., Gonzalez, R. Sexual dimorphism characterizes steroid hormone modulation of rat aortic steroid hormone receptors. Endocrinology 1986, 119: 296-302.
7. Colburn, P., Buonassisi, V. Estrogen-binding sites in endothelial cell cultures. Science 1978, 201: 817-9.
8. Ingegno, M.D., Money, S.R., Thelmo, W. et al. Progesterone receptors in the human heart and great vessels. Lab Invest 1988, 59: 353-6.
9. Lantta, M., Kärkkäinen, J., Lehtovirta, P. Progesterone and estradiol receptors in the cytosol of the human uterine artery. Amer J Obstet Gynecol 1983, 147: 627-33.
10. Bergqvist, A., Bergqvist, D., Ferno, M. Estrogen and progesterone receptors in vessel walls. Acta Obstet Gynecol Scand 1993, 72: 10-6.
11. Perrot-Applanat, M., Cohen-Solal, K., Milgrom, E., Finet, M. Progesterone receptor expression in human saphenous veins. Circulation 1995, 92: 2975-83.
12. Byrne, K.B., Stanton, B.J., Coupar, I.M., Burcher, E. Effect of levonorgestrel and ethinyloestradiol on vasoconstriction in rat isolated vasculature. J Pharm Pharmacol 1988, 40: 562-6.
13. 1-adrenergic receptors in altering uterine blood flow during the estrous cycle of gilts. Amer J Obstet Gynecol 1984, 150: 480-4.
14. Goldstein, D.S., Levinson, P., Keiser, H. R. Plasma and urinary catecholamines during the human ovulatory cycle. Amer J Obstet Gynecol 1983, 146: 824-9.
15. Lüscher, T.F., Boulanger, C.M., Yang, Z., Noll, G., Dohi, Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation 1993, 87 (Suppl. V): V36-44.
16. Willerson, J.T., Golino, P., Eidt, J., Campbell, W.B., Buja, L.M. Specific platelet mediators and unstable coronary artery lesions. Circulation 1989, 80: 198-205.
17. Polderman, K.H., Stehouwer, C.D.H., Van Kamp, G.J., Dekker, G.A., Verheugt, F.W.A., Gooren, L.J.G. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 1993, 118: 429-32.
18. Rosselli, M., Imthurn, B., Keller, P.J., Jackson, P.J., Dubey, R.K. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. Hypertension 1995, 25 (Pt 2): 848-53.
19. Miller, V.M., Vanhoutte, P.M. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Amer J Physiol 1991, 261: R1022-7.
20. Ylikorkala, O., Kuusi, T., Tikkanen, M.J., Viinikka, L. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins. J Clin Endocrinol Metab 1987, 65: 1238-42.
21. Kjaeldgaard, A., Ahlesteen, I., Larsson, B., Astedt, B. Progestogen regulation of tissue plasminogen activator in a human melanoma cell line. Thrombosis Res 1988, 49: 287-97.
22. Kjaeldgaard, A., Larsson, B., Astedt, B. Regulatory effect of contraceptive steroids on the release of tissue-type plasminogen activator in vitro. Contraception 1984, 30: 355-62.
23. Blei, F., Wilson, E.L., Mignatti, P., Rifkin, D.B. Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 1993, 155: 568-78.
24. Jiang, C., Sarrel, P.M., Lindsay, D.C., Poole-Wilson, P.A., Collins, P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol 1992, 211: 163-7.
25. Jiang, C., Sarrel, P.M., Lindsay, D.C., Poole-Wilson, P.A., Collins, P. Endothelium-independent relaxa tion of rabbit coronary artery by 17ß-oestradiol in vitro. Brit J Pharmacol 1991, 104: 1033-7.
26. Fischer, G.M., Swain, M.L. Influence of contraceptive and other sex steroids on aortic collagen and elastin. Exp Mol Pathol 1980, 33: 15-24.
27. Fischer, G.M., Swain, M.L. Effect of sex hormones on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Amer J Physiol 1977, 232: H617-21.
28. Hassager, C., Jensen, L.T., Podenphant, J., Riis, B.J., Christiansen, C. Collagen synthesis in postmenopausal women during therapy with anabolic steroid or female sex hormones. Metabolism 1990, 39: 1167-9.
29. Gammal, E.B. Intimal thickening in arteries of rats treated with synthetic sex hormones. Brit J Exp Pathol 1976, 57: 248-54.
30. Greiss, F.C., Anderson, S.G. Effect of ovarian hormones on the uterine vascular bed. Amer J Obstet Gynecol 1970, 107: 829-36.
31. Anderson, S.G., Hackshaw, B.T., Still, J.G., Greiss, F.C. Uterine blood flow and its distribution after chronic estrogen and progesterone administration. Amer J Obstet Gynecol 1977, 127: 138-42.
32. Resnik, R., Brink, G.W., Plumer, M.H. The effect of progesterone on estrogen-induced uterine blood flow. Amer J Obstet Gynecol 1977, 128: 251-4.
33. Batra, S., Bjeilin, L., Iosif, S., Martensson, L., Sjögren, C. Effect of oestrogen and progesterone on the blood flow in the lower urinary tract of the rabbit. Acta Physiol Scand 1985, 123: 191-4.
34. Sarrel, P.M. Sexuality and menopause. Obstet Gynecol 1990, 75: 26-30S.
35. Sarrel, P. Effects of ovarian steroids on the cardiovascular system. In: The Circulation in the Female. Ginsberg, J. (Ed.). Parthenon Hall: Carnforth, UK 1989, 117-41.
36. Hillard, T.C., Bourne, T.H., Whitehead, M.I., Crayford, T.B., Collins, W.P., Campbell, S. Differential effects of transdermal estradiol and sequential progestogens on impedance to flow within the uterine arteries of postmenopausal women. Fertil Steril 1992, 58: 959-63.
37. Marsh, M.S., Bourne, T.H., Whitehead, M.I., Collins, W.P., Campbell, S. The temporal effect of progestogen on uterine artery pulsatility index in postmenopausal women receiving sequential hormone replacement therapy. Fertil Steril 1994, 62: 771-4.
38. Sullivan, J.M., Shala, B.A., Miller, L.A., Lerner, J.L., McBrayer, J.D. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy. Menopause 1995, 2: 193-9.
39. Sarrel, P.M. How progestins compromise the cardioprotective effects of estrogens. Menopause 1995, 2: 187-90.
40. Penotii, M., Nencioni, T., Gabrielli, L., Farina, M., Castiglioni, E., Polvani, F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Amer J Obstet Gynecol 1993, 169: 1226-32.
41. Prelevic, G.M., Beljic, T. The effect of oestrogen and progestogen replacement therapy on systolic flow velocity in healthy postmenopausal women. Maturitas 1994, 20: 37-44.
42. Sarrel, P.M. Ovarian hormones and cardiovascular function. XIII World Cong Gynaecol Obstet (Sept 15-20, Singapore) 1991.
43. Williams, J.K., Honore, E.K., Washburn, S.A., Clarkson, T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Amer Cell Cardiol 1994, 24: 1757-61.
44. de Ziegler, D., Bessis, R., Frydman, R. Vascular resistance of uterine arteries: Physiological effects of estradiol and progesterone. Fertil Steril 1991, 55: 775-9.
45. de Ziegler, D. Effect of progestins on vascular tone? Fertit Steril 1993, 60: 590-2.
46. Steer, C.V., Campbell, S., Pampiglione, C., Kingsland, C.R., Mason, B.A., Collins, W.P. Transvaginal colour flow imaging of the uterine arteries during the ovarian and menstrual cycles. Human Reprod 1990, 5: 391-5.
47. Cano, A., Ballester, M.J., Balanza, R., Bonilla-Musoles, F. Effect of HRT on uterine arterial status in hypoestrogenic women. 7th Int Cong Menopause (June 20-24, Stockholm) 1993, Abst 116.
48. Forbes, T.R., Glassen, G. Steroid compounds and the dilatation of ovarian and uterine veins in the mouse. Amer J Obstet Gynecol 1972, 113: 678-80.
49. McCausland, A.M., Holmes, F., Trotter, A.D. Venous distensibility during the menstrual cycle. Amer J Obstet Gynecol 1963, 86: 640-5.
50. Goodrich, S.M., Wood, J.E. Peripheral venous distensibility and velocity of blood flow during pregnancy or during oral contraceptive therapy. Amer J Obstet Gynecol 1964, 90: 740-4.
51. Fawer, R., Dettling, A., Weihs, D., Welti, H., Schelling, J.L. Effect of the menstrual cycle, oral contraception and pregnancy on forearm blood flow, venous distensibility and clotting factors. Eur J Clin Pharmacol 1978, 13: 251-7.
52. Rieckert, H., Schneider, H.J., Schnitzer, W., Hguyen-Duong, H. Influence of contraceptives on function of vessel wall of caudal vein system. Thromb Diathes Haemorrhag 1971, 49: 163-7.
53. Rubanyi, G.M., Romero, J.C., Vanhoutte, P.M. Flow-induced release of endothelium-derived relaxing factor. Amer J Physiol 1986, 250: H1145-9.